Skip to main content
NIOX GROUP PLC logo

NIOX GROUP PLC — Investor Relations & Filings

Ticker · NIOX ISIN · GB00BJVD3B28 LEI · 2138006YAT138TOGA556 IL Manufacturing
Open in API
Filings indexed 147 across all filing types
Latest filing 2025-08-12 Major Shareholding Noti…
Country GB United Kingdom
Listing IL NIOX

About NIOX GROUP PLC

https://www.niox.com/

NIOX Group PLC is a medical device company specializing in the design, development, and commercialization of products for asthma diagnosis and management. The company's core offering is the NIOX® product line, which provides point-of-care measurement of Fractional exhaled Nitric Oxide (FeNO). This non-invasive diagnostic tool is used by physicians globally to help improve the diagnosis and management of asthma, with the aim of enhancing the quality of life for individuals with the condition.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership (crossing a threshold) for Niox Group PLC. This type of regulatory filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Niox Group PLC. It details a change in voting rights held by Danske Bank A/S, crossing a threshold. This is a classic major shareholding notification, which corresponds to the MRQ filing category.
2025-08-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Total Voting Rights' announcement issued by NIOX Group plc. It specifies the total number of issued shares and voting rights in accordance with the FCA's Disclosure and Transparency Rule 5.6.1. While it mentions share option exercises, it is primarily a regulatory disclosure regarding the denominator for shareholder notifications. Since it does not fit into specific categories like 'Share Issue' (which usually details the transaction itself) or 'Major Shareholding' (which is a notification from a shareholder), it is best classified as a general regulatory filing.
2025-08-01 English
PDMR/PCA Shareholding
Director's Dealing Classification · 1% confidence The document is titled 'Notification of a transaction by a Person Closely Associated ("PCA") with Persons Discharging Managerial Responsibilities ("PDMR")' and details the purchase of ordinary shares by an executive's PCA. This clearly falls under the category of insider trading reports or director's dealings. The presence of 'RNS Number' and the closing statement referencing RNS, the news service of the London Stock Exchange, indicates it is a regulatory announcement. The specific definition for Director's Dealing is 'Report of personal share transactions by company directors and executives (insider trades)', which matches the content perfectly. Therefore, the code is DIRS.
2025-07-22 English
Trading Update
Earnings Release Classification · 1% confidence The document is a 'Trading Update' issued by NIOX Group plc via the RNS (Regulatory News Service). It provides preliminary financial highlights for the six months ended 30 June 2025, including revenue growth and EBITDA figures. Crucially, the text explicitly states: 'NIOX expects to release its interim results for the six months ended 30 June 2025 on 30 September 2025.' This confirms the document is an initial announcement of financial performance (Earnings Release) rather than the full interim report itself. H1 2025
2025-07-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Ian Johnson, the Non-Executive Chairman of NIOX Group plc. It details the issuance of new ordinary shares under a Deferred Share Bonus Plan and includes the mandatory UK MAR (Market Abuse Regulation) disclosure table. While it also mentions a change in total voting rights, the primary purpose and the structure of the document (including the PDMR disclosure table) align perfectly with the 'Director's Dealing' category.
2025-06-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.